Lotus Pharmaceuticals, Inc. (LTUS)
OTCMKTS · Delayed Price · Currency is USD
0.0031
+0.0001 (3.33%)
At close: Nov 13, 2026
Lotus Pharmaceuticals Company Description
Lotus Pharmaceuticals, Inc. operates as a healthcare-focused company.
It focuses on participating in the healthcare and pharmaceutical industries through strategic investments, business development, partnerships, and industry integration.
The company seeks opportunities across the healthcare value chain, including hospitals, pharmaceutical companies, biotechnology enterprises, medical device manufacturers, healthcare service providers, digital healthcare platforms, and other healthcare-related businesses.
The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006.
Lotus Pharmaceuticals, Inc. is based in Irvine, California.
Lotus Pharmaceuticals, Inc.
| Country | United States |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 383 |
| CEO | Zhong Yi Liu |
Contact Details
Address: 127 Leafy Twig Irvine, California 92618 United States | |
| Phone | 949 591 3688 |
| Website | lotuspharmaceuticalsusa.com |
Stock Details
| Ticker Symbol | LTUS |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US5457152032 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zhong Yi Liu | Founder, Chairman, Chief Executive Officer and President |
| Yan Zeng | Chief Financial Officer and Principal Accounting Officer |
| Dr. Xing Shen Ph.D. | Vice President of Corporate Development |